In Vivo Search for Butyrate Responsive Sequences Using Transgenic Mice Carrying Gene Promoter Mutants

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.

  1995cited by this paper
• Transgenic mouse model of pharmacologic induction of fetal hemoglobin: Studies using a new ribonucleotide reductase inhibitor, didox

  1994cited by this paper
• Developmental regulation and butyrate-inducible transcription of the Xenopus histone H1(0) promoter.

  1993cited by this paper
• A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.

  1993cited by this paper
• Identification of sequence elements in mouse calbindin-D28k gene that confer 1,25-dihydroxyvitamin D3- and butyrate-inducible responses.

  1993cited by this paper
• Developmental regulation of human gamma-globin genes in transgenic mice

  1993cited by this paper
• Two cytotoxic cell proteinase genes are differentially sensitive to sodium butyrate.

  1992cited by this paper
• Identification of a stage selector element in the human gamma‐globin gene promoter that fosters preferential interaction with the 5′ HS2 enhancer when in competition with the beta‐promoter.

  1992cited by this paper
• Increased fetal hemoglobin in patients receiving sodium 4-phenylbutyrate.

  1992cited by this paper
• 5'-flanking sequences mediate butyrate stimulation of embryonic globin gene expression in adult erythroid cells

  1991cited by this paper
• Locus control region-A gamma transgenic mice: a new model for studying the induction of fetal hemoglobin in the adult.

  1991cited by this paper
• On the induction of fetal hemoglobin by butyrates: in vivo and in vitro studies with sodium butyrate and comparison of combination treatments with 5-AzaC and AraC.

  1989cited by this paper
• Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching.

  1988cited by this paper
• alpha-Amino-N-butyric acid stimulates fetal hemoglobin in the adult.

  1988cited by this paper
• Sodium butyrate activates human immunodeficiency virus long terminal repeat--directed expression.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• G to A substitution in the distal CCAAT box of the Aγ-globin gene in Greek hereditary persistence of fetal haemoglobin

  1985cited by this paper
• A point mutation in the Aγ-globin gene promoter in Greek hereditary persistence of fetal haemoglobin

  1985cited by this paper
• Activation of a chicken embryonic globin gene in adult erythroid cells by 5-azacytidine and sodium butyrate.

  1984cited by this paper
• Effects of sodium butyrate, a new pharmacological agent, on cells in culture

  1981cited by this paper

• Hydroxyurea Treatment for Sickle Cell Disease

  2002cites this paper
• MODULATION OF FETAL HEMOGLOBIN IN SICKLE CELL ANEMIA

  2001cites this paper
• Pharmacologic Induction of Fetal Hemoglobin Synthesis: Cellular and Molecular Mechanisms

  2001cites this paper
• Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin.

  2000cites this paper